ARTICLE | Clinical News
WinRho SDF regulatory update
April 18, 2005 7:00 AM UTC
FDA approved an sBLA for a liquid formulation of WinRho SDF rho immune globulin to treat immune thrombocytopenic purpura (ITP). The lyophilized version of WinRho SDF already is marketed. ...